Sub-Areas to Recent Onset:
Site-Specific Intervention
(3)
Systemic Intervention
(0)
Combination Therapy
(1)
(Journal Article): Mucosal Tolerance to Prevent Type 1 Diabetes: Can the Outcome Be Improved in Humans?
Hanninen A, Harrison LC
IN:
Rev Diabetic Stud
2004; 1(3):113-121
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)
ABSTRACT: The results of trials in which autoantigens have been fed to individuals affected by autoimmune diseases - multiple sclerosis, rheumatoid arthritis and type 1 diabetes - have been ... Click HERE for details
(Journal Article): CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
Thornton AM, Shevach EM
IN:
J Exp Med
1998; 188(2):287-296
Impact Factor(s) of J Exp Med: 14.588 (2004), 15.302 (2003), 15.34 (2001)
ABSTRACT: Peripheral tolerance may be maintained by a population of regulatory/suppressor T cells that prevent the activation of autoreactive T cells recognizing tissue-specific antigens. We... Click HERE for details
|
||